Video

Weighing Cost Vs. Cure in Hepatitis C Treatments

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Related Content
Women feeling unwell and sinus on gray background - Image credit: eddows | stock.adobe.com
June 4th 2025

Study: LYR-210 Shows Promise in Chronic Rhinosinusitis with Nasal Polyps

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Effects and treatment of statins concept photo. Open packaging with drugs tablets, on which is written "Statin Medication", lies near stethoscope, result analysis on cholesterol (lipid panel) and ECG
June 3rd 2025

Expert Q&A: Pharmacist-Led Strategies to Improve Cholesterol Management

Luke Halpern, Assistant Editor Amanda Gronniger, PharmD, CPh, BCCP
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image credit: catalin | stock.adobe.com
June 3rd 2025

ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape

Joshua Sabari, MD Kennedy Ferruggia, Assistant Editor
Non-small cell lung cancer (NSCLC) -- Image credit: MdBabul | stock.adobe.com
June 2nd 2025

ASCO 2025: Informing Treatment Decisions Using a 14-Gene Assay in Early-Stage NSCLC

Gillian McGovern, Associate Editor David Spigel, MD